Pathophysiology and Treatment of Premenstrual Syndrome

  • Robert L. Reid


The premenstrual syndrome (PMS) is a complex psychoneuroendocrine disorder that results in recurrent temporary disruption of the personal and professional lives of a substantial number of women throughout their reproductive years (Reid & Yen, 1981a). PMS is now recognized as an important factor contributing to marital discord, social isolation, and work inefficiency or absenteeism (Bickers & Wood, 1951; Dalton, 1964). Suicidal and psychotic behavior (Dalton, 1959; Endo, Daiguji, Asano, Yamashitu, & Takahashi, 1978; Glass, Heninger, Lansky, & Talan, 1971; Janowski, Gorney, Castelnuovo-Tedesco, & Stone, 1969; Mandell & Mandell, 1967; Tanks, Rach, & Rose, 1968), accidents requiring admission to the hospital (Dalton, 1960; MacKinnon & MacKinnon, 1956), and criminal activities including child battering, theft, and murder (Dalton, 1961, 1966, 1980; d’Orban & Dalton, 1980) are all reported as occurring with increased frequency in the premenstrual week, indicating that the adverse effects of PMS on both the individual and on society in general may be far-ranging. Conflicting theories about the pathophysiology of PMS and a host of alleged but unproven remedies have both confused and frustrated practitioners faced with the reality of treating affected individuals. The dissatisfaction and skepticism that this has generated among physicians has, in general, resulted in a disinterest in PMS which is mirrored by the paucity of information on this subject in most texts on obstetrics and gynecology. In a recent detailed review, this author has examined many of the controversies, both social and scientific, surrounding the topic of PMS (Reid, 1985).


Menstrual Cycle Luteal Phase Premenstrual Syndrome Menstrual Migraine Premenstrual Symptom 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abraham, G. E., 1980. Premenstrual tension.Current Problems in Obstetrics and Gynecology 3: 10.Google Scholar
  2. Abraham, G. E. and J. T. Hargrove, 1980. Effect of Vitamin B6 on premenstrual symptomatology in women with premenstrual tension syndromes: a double blind crossover study.Infertility 3: 155–165.Google Scholar
  3. Adams, P. W., D. P. Rose, J. Folkard, V. Wynn, M. Seed, and R. Strong, 1973. Effect of pyridoxine hydrochloride (Vitamin B6) upon depression associated with oral contraception.The Lancet 1: 897–904.CrossRefGoogle Scholar
  4. Anderson, A. N. and J. F. Larsen, 1979. Bromocriptine in the treatment of premenstrual syndrome.Drugs 17: 383–388.CrossRefGoogle Scholar
  5. Backstrom, C. T., H. Boyle, and D. T. Baird, 1981. Persistence of symptoms of premenstrual tension in hysterectomized women.British Journal of Obstetrics and Gynaecology 88: 530–536.PubMedCrossRefGoogle Scholar
  6. Berger, H., 1955. Ulcerative stomatitis caused by endogenous progesterone.Annals of Internal Medicine 42: 205–208.PubMedGoogle Scholar
  7. Bertoli, A., R. de Pirro, A. Fusco, A. V. Greco, R. Magnatta, and R. Lauro, 1980. Differences in insulin receptors between men and menstruating women and influence of sex hormones on insulin binding during the menstrual cycle.Journal of Clinical Endocrinology and Metabolism 50: 246-250.Google Scholar
  8. Bickers, W. and M. Woods, 1951. Premenstrual tension rational treatment.Texas Report on Biological Medicine 9: 406-A19.Google Scholar
  9. Chambers, M., 1982. Menstrual stresses as legal defenses.New York Times,May 29, p. 46.Google Scholar
  10. Christie, M. J. and G. B. Chester, 1982. Physical dependence on physiologically released endogenous opiates.Life Sciences 30: 1173–1177.PubMedCrossRefGoogle Scholar
  11. Cohen, M. R., R. M. Cohen, D. Pickar, H. Weingartner, D. L. Murphy, and W. Bunney, Jr., 1981. Behavioural effects after high dose naloxone administration to normal volunteers.The Lancet 2: 1110.CrossRefGoogle Scholar
  12. Cole, E. N., D. Everend, D. F. Horrobin, M. S. Manku, J. P. Mtabaji, and B. A. Nassar, 1975. Is prolactin a fluid and electrolyte regulating hormone in manJournal of Physiology (London) 252: 5P.Google Scholar
  13. Cullberg, J., 1972. Mood changes and menstrual symptoms with different gestagen estrogen combinations.Acta Psychiatrica Scandinavica 236: 1–86.Google Scholar
  14. Dalton, K., 1959. Menstruation and acute psychiatric illnesses.British Medical Journal 1: 148–149PubMedCrossRefGoogle Scholar
  15. Dalton, K., I960. Menstruation and accidents.British Medical Journal 2: 1425–1426.CrossRefGoogle Scholar
  16. Dalton, K., 1961. Menstruation and crime.British Medical Journal 2: 1752–1753.PubMedCrossRefGoogle Scholar
  17. Dalton, K., 1964. The influence of menstruation on health and disease.Proceedings of the Royal Society of Medicine 57: 18–20.Google Scholar
  18. Dalton, K., 1966. The influence of mother’s menstruation on her child.Proceedings of the Royal Society of Medicine 59: 1014–1016.PubMedGoogle Scholar
  19. Dalton, K., 1980. Cyclical criminal acts in premenstrual syndrome.The Lancet 2: 1070–1071.CrossRefGoogle Scholar
  20. Dawood, M. Y., 1981. Dysmenorrhea.American College of Obstetricians and Gynecologists Technical Bulletin No. 68,March.Google Scholar
  21. Day, J., 1979. Danazol and the premenstrual syndrome.Postgraduate Medical Journal 55: 87–89.PubMedCrossRefGoogle Scholar
  22. D’Orban, P. T., 1981. Premenstrual syndrome: a disease of the mind.The Lancet 2: 1413.CrossRefGoogle Scholar
  23. D’Orban, P. T. and K. Dalton, 1980. Violent crime and the menstrual cycle.Psychological Bulletin 10: 353–359.Google Scholar
  24. Edeiken, J. and J. Q. Griffith, Jr., 1940. Cyclic pulmonary edema at menses in mitral stenosis.Journal of the American Medical Association 115: 287–289.CrossRefGoogle Scholar
  25. Ellinwood, E. H., A. Sudilovsky, and L. M. Nelson, 1973. Evolving behaviour in the clinical and experimental amphetamine (model) psychosis.American Journal of Psychiatry 130: 1088.PubMedGoogle Scholar
  26. Endo, M., M. Daiguji, Y. Asano, I. Yamashitu, and S. Takahashi, 1978. Periodic psychosis recurring in association with the menstrual cycle.Journal of Clinical Psychiatry 39: 456–466.PubMedGoogle Scholar
  27. Ganon, L., 1981. Evidence for a psychological etiology of menstrual disorders: A critical review.Psychological Reports 48: 287–294.CrossRefGoogle Scholar
  28. Gianutsos, G. and H. Lal, 1978. Narcotic analgesics and aggression.Modern Problems in Pharmacopsychiatry 13: 114–138.Google Scholar
  29. Glass, G. S., G. R. Heninger, M. Lansky, and K. Talan, 1971. Psychiatric emergency related to the menstrual cycle.American Journal of Psychiatry 128: 705–711.PubMedGoogle Scholar
  30. Glick, D. and D. Stewart, 1980. A new drug treatment for premenstrual exacerbation of schizophrenia.Comprehensive Psychiatry 21:281–287.PubMedCrossRefGoogle Scholar
  31. Gold, M. S., A. C. Pottash, D. R. Sweeney, and H. D. Kleber, 1980. Opiate withdrawal using clonidine, a safe, effective and rapid non-opiate treatment.Journal of the American Medical Association 243: 346–353.Google Scholar
  32. Gowdey, C. W., 1983. A guide to the pharmacology of placebos.Canadian Medical Association Journal 128: 921–925.PubMedGoogle Scholar
  33. Grandison, L. and A. Guidotti, 1977. Stimulation of food intake by muscimol and Beta-endorphin.Neuropharmacology 16: 533–536.PubMedCrossRefGoogle Scholar
  34. Gray, C., 1981. Raging female hormones in the courts. McLeans Magazine, June 15, pp. 46–49.Google Scholar
  35. Greene, R. and K. Dalton, 1953. The premenstrual syndrome.British Medical Journal 1: 1007–1014.PubMedCrossRefGoogle Scholar
  36. Greenhill, J. P. and S. C. Freed, 1941. The electrolyte therapy of premenstrual distress.Journal of the American Medical Association 117: 504–506.CrossRefGoogle Scholar
  37. Halbreich, U., M. Ben-David, M. Assael, and R. Bornstein, 1976. Serumprolactin in women with premenstrual syndrome.The Lancet 2: 654–656.CrossRefGoogle Scholar
  38. Janowski, D. S., R. Gorney, P. Castelnuovo-Tedesco, and C. B. Stone, 1969. Premenstrual-menstrual increases in psychiatric hospital admission rates.American Journal of Obstetrics and Gynecology 103: 189–191.Google Scholar
  39. Kerr, G. D., 1977. The management of the premenstrual syndrome.Current Medical Research Opinion 4(Suppl.): 29–34..Google Scholar
  40. Lai, H. and S. K. Puri, 1972. Morphine withdrawal aggression: role of dopaminergic stimulation. In: J. M. Singh, 1. Miller, and H.Google Scholar
  41. Lai (Eds.), Drug Addiction: Experimental Pharmacology. Futura Publishing Co., Mount Kisco, New York, pp. 301-310.Google Scholar
  42. Levine, J. D., N. C. Gordon, and H. L. Fields, 1978. The mechanism of placebo analgesia.The Lancet 2: 654–657.CrossRefGoogle Scholar
  43. Llorens, C., M. P. Martres, M. Bandry, and J. C. Schwartz, 1978. Hypersensitivity to noradrenaline in cortex after chronic morphine: relevance to tolerance and dependence.Nature 274: 603–605.PubMedCrossRefGoogle Scholar
  44. Macgregor, G. A., J. E. Roulston, N. D. Markandu, H. E. de Wardener, and J. C. Jones, 1979. Is “idiopathic” edema idiopathicThe Lancet 1: 397–400.CrossRefGoogle Scholar
  45. MacKinnon, P.C.B. and I. L. MacKinnon, 1956. Hazards of the menstrual cycle.British Medical Journal 1: 555.PubMedCrossRefGoogle Scholar
  46. Maddocks, S., F. Moller, P. Hahn, and R. L. Reid, 1986. A double-blind, placebo-controlled trial of progesterone vaginal suppositories in the treatment of premenstrual syndrome.American Journal of Obstetrics and Gynecology,in press.Google Scholar
  47. Magos, A. L., K. J. Zilkha, and J.W.W. Studd, 1983. Treatment of menstrual migraines by oestradiol implants.Journal of Neurology, Neurosurgery & Psychiatry 46: 1044–1046.CrossRefGoogle Scholar
  48. Mandell, A. J. and M. P. Mandell, 1967. Suicide and the menstrual cycle.Journal of the American Medical Association 200: 792–793.PubMedCrossRefGoogle Scholar
  49. Melody, G. F., 1961. Behavioural implications of premenstrual tension.Obstetrics and Gynaecology 17: 439–441.Google Scholar
  50. Morton, J. H., 1950. Premenstrual tension.American Journal of Obstetrics and Gynecology 60: 343–352.PubMedGoogle Scholar
  51. Morton, J. H., H. Addison, R. G. Addison, 1. Hunt, and J. J. Sullivan, 1953. A clinical study of premenstrual tension.American Journal of Obstetrics and Gynecology 65: 1182–1191.PubMedGoogle Scholar
  52. Muse, K. N., N. S. Cetel, L. A. Futterman, and S.S.C. Yen, 1984. The premenstrual syndrome: Effects of “medical ovariectomy.”New England Journal of Medicine 311: 1345–1349.PubMedCrossRefGoogle Scholar
  53. O’Brien, P.M.S., D. Craven, C. Selby, and E. M. Symonds, 1979. Treatment of premenstrual syndrome by spironolactone.British Journal of Obstetrics and Gynaecology 86: 142–147.PubMedCrossRefGoogle Scholar
  54. Perr, 1. N., 1958. Medical, psychiatric, and legal aspects of premenstrual tension.American Journal of Psychiatry 115: 211–219.PubMedGoogle Scholar
  55. Quigley, M. E. and S.S.C. Yen, 1980. The role of endogenous opiates on LH secretion during the menstrual cycle.Journal of Clinical Endocrinology and Metabolism 51: 179–181.PubMedCrossRefGoogle Scholar
  56. Reid, R. L., 1983. Endogenous opioid activity in premenstrual syndrome.The Lancet 2: 786.CrossRefGoogle Scholar
  57. Reid, R. L., 1985. Premenstrual syndrome.Current Problems in Obstetrics, Gynecology, and Fertility 8: 1–57.Google Scholar
  58. Reid, R. L., 1986. Clinical opinion. Premenstrual syndrome: A time for introspection.American Journal of Obstetrics and Gynecology, in press.Google Scholar
  59. Reid, R. L., A. Greenaway-Coates, and P. M. Hahn, 1986. Oral glucose tolerance during the menstrual cycle in normal women (NW) and women with alleged premenstrual “hypoglycemic” attacks (PMHA): Effects of Naloxone.Journal of Clinical Endocrinology and Metabolism, in press.Google Scholar
  60. Reid, R. L. and S.S.C. Yen, 1981a. Premenstrual syndrome.American Journal of Obstetrics and Gynecology 139: 85–104.PubMedGoogle Scholar
  61. Reid, R. L. and S.S.C. Yen, 1981b. ß-endorphin stimulates the secretion of insulin and glucagon in human. Journal of Clinical Endocrinologyand Metabolism 52: 592–594PubMedCrossRefGoogle Scholar
  62. Reid, R. L. and S.S.C. Yen, 1983. The premenstrual syndrome.Clinical Obstetrics and Gynaecology 26: 710–718.CrossRefGoogle Scholar
  63. Sampson, G. A., 1979. Premenstrual syndrome: A double-blind controlled trial of progesterone and placebo.British Journal of Psychiatry 135: 209–215.PubMedCrossRefGoogle Scholar
  64. Sampson, G. A., 1981. An appraisal of the role of progesterone in the therapy of premenstrual syndrome. In: P. A. van Keep (Ed.),The Premenstrual Syndrome. MTP Press Ltd. (Falcon House International Publishers), Lancaster, England, pp. 51–69.CrossRefGoogle Scholar
  65. Schaumburg, H., J. Kaplan, A. Windebank, N. Vick, S. Rasmus, D. Pleasure, and M. J. Brown, 1983. Sensory neuropathy from pyridoxine abuse.New England Journal of Medicine 309: 445–448.PubMedCrossRefGoogle Scholar
  66. Somerville, B. W., 1972. The role of oestradiol withdrawal in the etiology of menstrual migraine.Neurology (Minneapol.) 22: 355–365.Google Scholar
  67. Steiner, M., R. F. Haskett, and B. J. Carroll, 1980a. Premenstrual tension syndrome: The development of research diagnostic criteria and new rating scales.Acta Psychiatrica Scandinavica 62: 177–190.PubMedCrossRefGoogle Scholar
  68. Steiner, M., R. F. Haskett, J. M. Osmun, and B. J. Carroll, 1980b. Treatment of premenstrual tension with lithium carbonate: A pilot study.Acta Psychiatrica Scandinavica 61: 96–102.PubMedCrossRefGoogle Scholar
  69. Stewart, N. L., 1957a. Psychotic aspects of premenstrual tension.Cleveland-Marshall Law Review 6: 410–427.Google Scholar
  70. Stewart, N. L., 1957b. Premenstrual tension in automobile accidents.Cleveland-Marshall Law Review 6: 17–30.Google Scholar
  71. Stokes, J. and J. Mendels, 1972. Pyridoxine and premenstrual tension.The Lancet 1: 1177–1178.CrossRefGoogle Scholar
  72. Suarez-Murias, E. L., 1953. The psychophysiologic syndrome of premenstrual tension with emphasis on the psychiatric aspect.International Record of Medicine 166: 475–486.Google Scholar
  73. Tanks, C. M., P. H. Rach, and M. J. Rose, 1968. Attempted suicide and the menstrual cycle.Journal of Psychosomatic Research 11: 319–323.CrossRefGoogle Scholar
  74. Thier, S. O., 1977. Breast cancer screening: A view from outside the controversy.New England Journal of Medicine 297: 1063.PubMedCrossRefGoogle Scholar
  75. Wald, A., D. H. Van Thiel, L. Hoechstetter, J. S. Gavaler, K. M. Egler, R. Verm, L. Scott, and R. Lester, 1981. Gastrointestinal transit: The effect of the menstrual cycle.Gastroenterology 80: 1497–1500.PubMedGoogle Scholar
  76. Wardlaw, S. L., W. B. Wehrenberg, M. Ferin, J. L. Antunes, and A. G. Frantz, 1982. Effect of sex steroids on ß-endorphin in hypophyseal portal blood.Journal of Clinical Endocrinology and Metabolism 55: 877–881.PubMedCrossRefGoogle Scholar
  77. Wehrenberg, W. B., S. L. Wardlaw, A. G. Frantz, and M. Ferin, 1982. 3-Endorphin in hypophyseal portal blood variations throughout the menstrual cycle.Endocrinology 111: 879–881.PubMedCrossRefGoogle Scholar
  78. Wei, E. and H. Loh, 1976. Physical dependence on opiate-like peptides.Science 193: 1262–1263.PubMedCrossRefGoogle Scholar
  79. Wood, C. and D. Jakubowicz, 1980. The treatment of premenstrual symptoms with mefenamic acid.British Journal of Obstetrics and Gynaecology 87: 627–630.PubMedCrossRefGoogle Scholar
  80. Woods, N. F., A. Most, and G. K. Dery, 1982. Prevalence of perimenstrual symptoms.American Journal of Public Health 72: 1257–1264.PubMedCrossRefGoogle Scholar
  81. Yen, S.S.C., 1983. Clinical applications of gonadotropin releasing hormone and gonadotropin releasing hormone analogs.Fertility and Sterility 39: 257–266.PubMedGoogle Scholar
  82. Zondek, B. and Y. M. Bromberg, 1947. Clinical reactions of allergy to endogenous hormones and their treatment.British Journal of Obstetrics and Gynaecology 54: 1–19.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1987

Authors and Affiliations

  • Robert L. Reid
    • 1
  1. 1.Division of Reproductive Endocrinology, Department of Obstetrics and GynaecologyQueen’s UniversityKingstonCanada

Personalised recommendations